Crystalline ultrastructures, inflammatory elements, and neoangiogenesis are present in inconspicuous aortic valve tissue

Cardiology Research and Practice

Volumn 1, Issue 1, 2010, Pages

  Dorfmuller P ^a,b   Bazin, D ^c   Aubert, S ^a   Weil, R ^c   Brisset, F ^c   Daudon, M ^c   Capron, F ^a   Brocheriou I ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c UNIVERSITÉ PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HYDROXYAPATITE; INTERLEUKIN 6; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; AORTA VALVE; AORTA VALVE DISEASE; ARTERY CALCIFICATION; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INFRARED SPECTROSCOPY; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCANNING ELECTRON MICROSCOPY; X RAY FLUORESCENCE;

EID: 79959449040     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.4061/2010/685926     Document Type: Article

References (39)

1. Farzaneh-Far A., Proudfoot D., Shanahan C., Weissberg P. L., Vascular and valvar calcification: recent advances Heart 2001 85 1 13 17 (Pubitemid 32973397)
2. O'Brien K. D., Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more) Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 8 1721 1728 (Pubitemid 44305324)
3. Li Y. B., Hu C. L., Liu J., Tang QI. Z., Huang C. X., Calcific aortic valve disease should not be considered as a degenerative disease anymore Medical Hypotheses 2007 68 6 1233 1235 (Pubitemid 46498425)
4. Rosenhek R., Rader F., Loho N., Gabriel H., Heger M., Klaar U., Schemper M., Binder T., Maurer G., Baumgartner H., Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis Circulation 2004 110 10 1291 1295 (Pubitemid 39202347)
5. Mohler E. R., Gannon F., Reynolds C., Zimmerman R., Keane M. G., Kaplan F. S., Bone formation and inflammation in cardiac valves Circulation 2001 103 11 1522 1528 (Pubitemid 32226259)
6. Sucosky P., Balachandran K., Elhammali A., Jo H., Yoganathan A. P., Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF- 1-dependent pathway Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 2 254 260
7. Hakuno D., Kimura N., Yoshioka M., Fukuda K., Molecular mechanisms underlying the onset of degenerative aortic valve disease Journal of Molecular Medicine 2009 87 1 17 24
8. Federsppiel B., Melhado I. G., Duncan A. M. V., Delaney A., Schappert K., Clark- Lewis I., Jirik F. R., Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen Genomics 1993 16 3 707 712 (Pubitemid 23183492)
9. Nomura H., Nielsen B. W., Matsushima K., Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors International Immunology 1993 5 10 1239 1249 (Pubitemid 23308083)
10. Loetscher M., Geiser T., O'Reilly T., Zwahlen R., Baggiolini M., Moser B., Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes Journal of Biological Chemistry 1994 269 1 232 237 (Pubitemid 24026649)
11. Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., Springer T. A., The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry Nature 1996 382 6594 829 833 (Pubitemid 26299570)
12. Oberlin E., Amara A., Bachelerie F., Bessia C., Virelizier J. L., Arenzana- Seisdedos F., Schwartz O., Heard J. M., Clark-Lewis I., Legler D. F., Loetscher M., Baggiolini M., Moser B., The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 Nature 1996 382 6594 833 835 (Pubitemid 26299571)
13. Bleul C. C., Fuhlbrigge R. C., Casasnovas J. M., Aiuti A., Springer T. A., A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) Journal of Experimental Medicine 1996 184 3 1101 1109 (Pubitemid 26313567)
14. Aiuti A., Webb I. J., Bleul C., Springer T., Gutierrez-Ramos J. C., The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood Journal of Experimental Medicine 1997 185 1 111 120 (Pubitemid 27039446)
15. Jo D. Y., Rafii S., Hamada T., Moore M. A. S., Chemotaxis of primitive hematopoietic cells in response to stromal cell- derived factor-1 Journal of Clinical Investigation 2000 105 1 101 111 (Pubitemid 30036392)
16. Jin D. K., Shido K., Kopp H. G., Petit I., Shmelkov S. V., Young L. M., Hooper A. T., Amano H., Avecilla S. T., Heissig B., Hattori K., Zhang F., Hicklin D. J., Wu Y., Zhu Z., Dunn A., Salari H., Werb Z., Hackett N. R., Crystal R. G., Lyden D., Rafii S., Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes Nature Medicine 2006 12 5 557 567
17. Walter D. H., Rochwalsky U., Reinhold J., Seeger F., Aicher A., Urbich C., Spyridopoulos I., Chun J., Brinkmann V., Keul P., Levkau B., Zeiher A. M., Dimmeler S., Haendeler J., Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 2 275 282 (Pubitemid 46143040)
18. Zernecke A., Shagdarsuren E., Weber C., Chemokines in atherosclerosis an update Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 11 1897 1908
19. Holm P. W., Slart R. H. J. A., Zeebregts C. J., Hillebrands J. L., Tio R. A., Atherosclerotic plaque development and instability: a dual role for VEGF Annals of Medicine 2009 41 4 257 264
20. Ferrara N., Gerber H. P., LeCouter J., The biology of VEGF and its receptors Nature Medicine 2003 9 6 669 676 (Pubitemid 36749215)
21. Maurice-Estepa L., Levillain P., Lacour B., Daudon M., Advantage of zero-crossing-point first-derivative spectrophotometry for the quantification of calcium oxalate crystalline phases by infrared spectrophotometry Clinica Chimica Acta 2000 298 1-2 1 11 (Pubitemid 30392451)
22. Mikroulis D., Mavrilas D., Kapolos J., Koutsoukos P. G., Lolas C., Physicochemical and microscopical study of calcific deposits from natural and bioprosthetic heart valves. Comparison and implications for mineralization mechanism Journal of Materials Science: Materials in Medicine 2002 13 9 885 889
23. Bunjes H., Steiniger F., Richter W., Visualizing the structure of triglyceride nanoparticles in different crystal modifications Langmuir 2007 23 7 4005 4011 (Pubitemid 46581934)
24. Unruh T., Westesen K., Bsecke P., Lindner P., Koch M. H. J., Self-assembly of triglyceride nanocrystals in suspension Langmuir 2002 18 5 1796 1800 (Pubitemid 35383990)
25. Miller J. D., Chu YI., Brooks R. M., Richenbacher W. E., Pea-Silva R., Heistad D. D., Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans Journal of the American College of Cardiology 2008 52 10 843 850
26. Hurle J. M., Colvee E., Fernandez-Teran M. A., The surface anatomy of the human aortic valve as revealed by scanning electron microscopy Anatomy and Embryology 1985 172 1 61 67 (Pubitemid 15054519)
27. Riddle J. M., Wang C. H., Magilligan D. J., Stein P. D., Scanning electron microscopy of surgically excised human mitral valves in patients over 45 years of age American Journal of Cardiology 1989 63 7 471 477 (Pubitemid 19065325)
28. Mirzaie M., Meyer T., Schwarz P., Lotfi S., Rastan A., Schndube F., Ultrastructural alterations in acquired aortic and mitral valve disease as revealed by scanning and transmission electron microscopical investigations Annals of Thoracic and Cardiovascular Surgery 2002 8 1 24 30
29. Mohler E. R., Mechanisms of aortic valve calcification American Journal of Cardiology 2004 94 11 1396 1402
30. Simmons C. A., Grant G. R., Manduchi E., Davies P. F., Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves Circulation Research 2005 96 7 792 799 (Pubitemid 40559519)
31. Fox C. S., Guo C. Y., Larson M. G., Vasan R. S., Parise H., O'Donnell C. J., D'Agostino R. B., Keaney J. F., Benjamin E. J., Relations of inflammation and novel risk factors to valvular calcification American Journal of Cardiology 2006 97 10 1502 1505
32. Shavelle D. M., Katz R., Takasu J., Lima J. A., Jenny N. S., Budoff M. J., O'Brien K. D., Soluble intercellular adhesion molecule-1 (sICAM-1) and aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis (MESA) Journal of Heart Valve Disease 2008 17 4 388 395
33. Ewence A. E., Bootman M., Roderick H. L., Skepper J. N., McCarthy G., Epple M., Neumann M., Shanahan C. M., Proudfoot D., Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization Circulation Research 2008 103 5 e28 e34
34. Rajamannan N. M., Nealis T. B., Subramaniam M., Pandya S., Stock S. R., Ignatiev C. I., Sebo T. J., Rosengart T. K., Edwards W. D., McCarthy P. M., Bonow R. O., Spelsberg T. C., Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation Circulation 2005 111 24 3296 3301 (Pubitemid 40875003)
35. Chalajour F., Treede H., Gehling U. M., Ebrahimnejad A., Boehm D. H., Riemer R. K., Ergun S., Reichenspurner H., Identification and characterization of cells with high angiogenic potential and transitional phenotype in calcific aortic valve Experimental Cell Research 2007 313 11 2326 2335 (Pubitemid 46891464)
36. Chalajour F., Treede H., Ebrahimnejad A., Lauke H., Reichenspurner H., Ergun S., Angiogenic activation of valvular endothelial cells in aortic valve stenosis Experimental Cell Research 2004 298 2 455 464 (Pubitemid 38950862)
37. Hakuno D., Kimura N., Yoshioka M., Fukuda K., Molecular mechanisms underlying the onset of degenerative aortic valve disease Journal of Molecular Medicine 2009 87 1 17 24
38. Skowasch D., Schrempf S., Wernert N., Steinmetz M., Jabs A., Tuleta I., Welsch U., Preusse C. J., Likungu J. A., Welz A., Lderitz B., Bauriedel G., Cells of primarily extravalvular origin in degenerative aortic valves and bioprostheses European Heart Journal 2005 26 23 2576 2580 (Pubitemid 41677310)
39. Wragg A., Mellad J. A., Beltran L. E., Konoplyannikov M., San H., Boozer S., Deans R. J., Mathur A., Lederman R. J., Kovacic J. C., Boehm M., VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism Journal of Molecular Medicine 2008 86 11 1221 1232